DRUG-ELUTING STENTS IN THE TREATMENT OF PATIENTS WITH OCCLUSIVE-STENOTIC LESIONS OF THE SUPERFICIAL FEMORAL ARTER-Reference-Cited by-同舟云学术

DRUG-ELUTING STENTS IN THE TREATMENT OF PATIENTS WITH OCCLUSIVE-STENOTIC LESIONS OF THE SUPERFICIAL FEMORAL ARTER

Published:2023 Issue:5 Volume:76 Page:1216-1219
ISSN:0043-5147
Container-title:Wiadomości Lekarskie
language:en
Short-container-title:Wiad Lek

Author:

Nikishyn Oleksandr L.¹,Altman Igor V.¹,Al-Qashkish Iyad I.¹,Gavretskiy Anatoliy I.²,Savolyuk Sergyi I.³,Muz Mykola I.⁴

Affiliation:

1. SI «SCIENTIFIC-PRACTICAL CENTER OF ENDOVASCULAR NEURORADIOLOGY NAMS OF UKRAINE», KYIV, UKRAINE

2. UKRAINIAN MILITARY MEDICAL ACADEMY, KYIV, UKRAINE

3. SHUPYK NATIONAL HEALTHCARE UNIVERSITY OF UKRAINE, KYIV, UKRAINE

4. KYIV CITY CLINICAL HOSPITAL № 8, KYIV, UKRAINE

Abstract

The aim: To analyze the results of endovascular revascularization of the femoropopliteal segment using drug-eluting stents. Materials and methods: Endovascular intervention was performed in 23 patients with occlusive-stenotic lesions of the superficial femoral artery (SFA). Paclitaxel-eluting stents were used. There were 16 (69.6%) patients with diabetes mellitus type 2 and diabetic angiopathy, and 7 (30.4%) patients had obliterating atherosclerosis of the arteries of the lower limbs. Critical ischemia of the lower extremities was diagnosed in 18 (78.3%) cases, and intermittent claudication - in 5 (21.7%). Results: Twenty (86.6 %) scheduled procedures for stenting of the SFA were technically successful. During follow-up period (3 months), there were no cases of reocclusion or clinically significant restenosis at the stented level. There were no “major” amputations during follow -up period. “Small” ankle amputations were performed in 7 (35%) patients with diabetic gangrene. Conclusions: Implantation of drug-eluting stents is an effective method of endovascular revascularization in patients with SFA lesions. To compare the results of implantation of drug-eluting stents with other methods of revascularization of the lesions of the femoro-popliteal segment, it is necessary to accumulate more data and increase the duration of the follow-up period.

Publisher

ALUNA

Subject

General Medicine

Reference9 articles.

1. 1. Nikishyn OL, Muz MI, Havretskyi AI et al. Aktualni pytannia vykorystannia stentuvannia u likuvanni krytychnoi ishemii nyzhnikh kintsivok [Current issues of using stenting in the treatment of critical ischemia of the lower extremities]. Endovascular neuroradiological surgery. 2017;(4):23-7 doi: 10.26683/2304-9359-2017-4(22)-23-27. (In Ukrainian).

2. 2. Antonopoulos CN, Mylonas SN, Moulakakis KG et al. A network meta-analysis of randomized controlled trials comparing treatment modalities for de novo superficial femoral artery occlusive lesions. J Vasc Surg. 2017;65(1):234-45.e11. doi: 10.1016/j.jvs.2016.08.095.

3. 3. Kayssi A, Al-Atassi T, Oreopoulos G et al. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs. Cochrane Database Syst Rev. 2016;2016(8):CD011319. doi: 10.1002/14651858.CD011319.pub2.

4. 4. Jongsma H, Bekken JA, de Vries JP et al. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty in patients with femoropopliteal arterial occlusive disease. J Vasc Surg. 2016;64(5):1503-14. doi: 10.1016/j.jvs.2016.05.084.

5. 5. Rekomendatsii z vedennia patsiientiv iz khronichnoiu ishemiieiu nyzhnikh kintsivok [Recommendations for the Management of Patients with Chronic Lower Limb Ischemia] https://health-ua.com/article/63987-rekomendatc-zvedennya-patcntv--zhronchnoyu-shemyu-nizhnh-kntcvok [date access 05.03.2021] (In Ukrainian)